THE RETATRUTIDE DIARIES

−/− mice demonstrated the retention of glucoregulatory effects but a major reduction during the weightloss outcomes. This emphasised the important function of GCGR activation during the metabolic steps of the tri-agonist. Notably, when an acylated GCGR agonist was administered alone, it resulted in close to 20% fat loss in mice on the substanti